An established 51-year-old male patient comes to the clinic for follow-up of medication-resistant hypertension. His blood pressure remains consistently above 150/90 mmHg despite documented adherence to a daily regimen consisting of maximally tolerated doses of amlodipine, lisinopril, and chlorthalidone. A routine comprehensive metabolic panel reveals a serum potassium concentration of 2.8 mEq/L. The clinical picture is highly suspicious for primary hyperaldosteronism. Arrange the following diagnostic and evaluative steps in the most appropriate evidence-based sequence, progressing from initial investigation to definitive pre-surgical assessment.
- 1Calculate the ratio of morning plasma aldosterone concentration to plasma renin activity.
- 2Perform a biochemical suppression test, such as an intravenous saline load or oral sodium loading.
- 3Obtain a high-resolution computed tomography (CT) scan of the adrenal glands.
- 4Conduct bilateral adrenal venous sampling to differentiate unilateral from bilateral disease.
Answer
The correct sequence is: 1) Plasma aldosterone-to-renin ratio, 2) Confirmatory suppression test (e.g., saline load), 3) Adrenal CT scan, 4) Adrenal venous sampling.
The diagnostic algorithm for primary hyperaldosteronism requires rigorous sequential testing to minimize false positives and avoid unnecessary invasive procedures. Screening begins with the aldosterone-to-renin ratio. If positive, autonomous secretion is biochemically confirmed via sodium loading or saline infusion. Only after biochemical confirmation should anatomic imaging (CT) be performed to localize the source, avoiding the diagnostic trap of adrenal incidentalomas. Finally, because imaging cannot definitively prove function, adrenal venous sampling is required before surgical management to confirm whether the excess aldosterone is produced unilaterally (curable by surgery) or bilaterally (managed medically).
Step-by-Step Solution
Key Concept
The diagnostic evaluation of primary hyperaldosteronism strictly follows a sequence of screening (aldosterone/renin ratio), biochemical confirmation (suppression testing), anatomic localization (adrenal CT), and functional subtyping (adrenal venous sampling).